FEED the BULL

Welcome to Feed the Bull - A home for investment information and interaction.

Tag: OncoGenex

Sort
E.g., 2013-05-20
E.g., 2013-05-20
Enter a comma separated list of user names.

OncoGenex Pharmaceuticals, Inc. (NASDAQ:OGXI) announced that data from two studies, a Phase II clinical study and a pre-clinical study, evaluating the investigational compound custirsen (OGX-011/TV-1011), were published in the September issues of the journals Clinical Cancer Research and Cancer Research.

ADVERTISE WITH US